期刊文献+

重症肝病并发侵袭性真菌病的诊治 被引量:2

Diagnosis and treatment of invasive fungal diseases in patients with severe liver diseases
下载PDF
导出
摘要 重症肝病并发侵袭性真菌病(IFD)是影响重症肝病患者预后的重要因素,其早期诊断仍是困扰临床医生的重要问题。临床最常见的4种IFDs是念珠菌病、曲菌病、隐球菌病以及肺孢子菌肺炎,在重症肝病患者临床诊疗过程中重视并发IFD的可能,尤其对存在高危因素的患者,及早发现、及时诊断、恰当治疗,对改善危重症肝病的预后至关重要。 Invasive fungal diseases( IFDs) are an important factor affecting the prognosis of patients with severe liver diseases,and their early diagnosis remains a challenge for clinicians. The four most commonly seen IFDs are candidiasis,aspergillosis,cryptococcosis,and pneumocystis pneumonia. We should pay attention to the risk of developing IFDs in patients with severe liver diseases during clinical management. Particularly,early diagnosis and proper treatment of IFDs are important in high- risk patients. These are vital to improving the prognosis of patients with severe liver diseases.
作者 臧红 辛绍杰
出处 《临床肝胆病杂志》 CAS 2016年第9期1694-1698,共5页 Journal of Clinical Hepatology
关键词 肝疾病 真菌病 诊断 治疗 liver diseases mycoses diagnosis therapy
  • 相关文献

参考文献4

二级参考文献39

  • 1黄云平,黄妙儿,陈华,杨雪英.真菌感染与白细胞相关因素研究[J].中华医院感染学杂志,2006,16(6):630-632. 被引量:15
  • 2Bennet JE.Echinocandins for candidemia in adults without neu-tropenia[J].N Engl J Med,2006,355(11):1154-1159. 被引量:1
  • 3Pfaller MA,Pappas PG,Wingard JR.Invasive fungal patho-gens:current epidemiological trends[J].Clin Infect Dis,2006,43(Suppl 1):S3-14. 被引量:1
  • 4Pfaller MA,Diekema DJ.Rare and emerging opportunistic fun-gal pathogens:concern for resistance beyond Candida albicansand Aspergillus fumigatus[J].J Clin Microbiol,2004,42(10):4419-4431. 被引量:1
  • 5Segal BH,Almyroudis NG,Battiwalla M,et al.Prevention andearly treatment of invasive fungal infection in patients with canc-er and neutropenia and in stem cell transplant recipients in theera of newer broad-spectrum antifungal agents and diagnostic ad-juncts[J].Clin Infect Dis,2007,44(3):402-409. 被引量:1
  • 6Cornely OA,Maertens J,Bresnik M,et al.AmBiLoad Trial StudyGroup.Liposomal amphotericin B as initial therapy for invasivemold infection:a randomized trial comparing a high-loading doseregimen with standard dosing(AmBiLoad Trial)[J].Clin InfectDis,2007,44(10):1289-1297. 被引量:1
  • 7Johnson LB,Kauffman CA.Voriconazole:a new triazole antifun-gal agent[J].Clin Infect Dis,2003,36(5):630-637. 被引量:1
  • 8Dannaoui E,Meletiadis J,Mouton JW,et al.In vitro susceptibili-ties of zygomycetes to conventional and new antifungals[J].JAntimicrob Chemother,2003,51(1):45-52. 被引量:1
  • 9Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole ver-sus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(8):408-415. 被引量:1
  • 10Perfect JR,Marr KA,Walsh TJ,et al.Voriconazole treatment forless common,emerging,or refractory fungal infections[J].ClinInfect Dis,2003,36(9):1122-1131. 被引量:1

共引文献653

同被引文献24

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部